Swiss National Bank Travere Therapeutics, Inc. Transaction History

Swiss National Bank

$137 Billion
Q1 2025

A detailed history of Swiss National Bank transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 158,100 shares of TVTX stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

158,100

Previous 151,900 4.08%

Holding current value

$2.5 Million

Previous $2.65 Million 7.07%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$17.07 - $23.75 $105,834 - $147,250	6,200 Added 4.08%	158,100 $2.83 Million
Q4 2024 Feb 10, 2025	BUY	$13.65 - $19.85 $234,780 - $341,420	17,200 Added 12.77%	151,900 $2.65 Million
Q2 2024 Aug 08, 2024	SELL	$5.26 - $8.28 $67,854 - $106,811	-12,900 Reduced 8.74%	134,700 $1.11 Million
Q3 2023 Nov 08, 2023	BUY	$7.64 - $17.25 $74,108 - $167,325	9,700 Added 7.03%	147,600 $1.32 Million
Q2 2023 Aug 09, 2023	SELL	$15.3 - $22.61 $42,840 - $63,308	-2,800 Reduced 1.99%	137,900 $2.12 Million
Q1 2023 May 10, 2023	BUY	$17.82 - $22.89 $167,508 - $215,166	9,400 Added 7.16%	140,700 $3.16 Million
Q4 2022 Feb 08, 2023	BUY	$18.47 - $26.14 $60,950 - $86,262	3,300 Added 2.58%	131,300 $2.76 Million
Q3 2022 Nov 09, 2022	BUY	$22.91 - $28.63 $32,074 - $40,082	1,400 Added 1.11%	128,000 $3.15 Million
Q2 2022 Aug 09, 2022	SELL	$20.94 - $30.01 $77,478 - $111,037	-3,700 Reduced 2.84%	126,600 $3.07 Million
Q1 2022 May 09, 2022	BUY	$23.61 - $30.6 $238,461 - $309,060	10,100 Added 8.4%	130,300 $3.36 Million
Q3 2021 Nov 08, 2021	BUY	$12.98 - $25.03 $76,582 - $147,677	5,900 Added 5.16%	120,200 $2.92 Million
Q2 2021 Aug 06, 2021	SELL	$14.11 - $26.4 $59,262 - $110,880	-4,200 Reduced 3.54%	114,300 $1.67 Million
Q1 2021 May 07, 2021	BUY	$23.37 - $31.77 $483,759 - $657,639	20,700 Added 21.17%	118,500 $2.96 Million
Q4 2020 Feb 05, 2021	BUY	$19.17 - $27.87 $1.87 Million - $2.73 Million	97,800 New	97,800 $2.67 Million

Others Institutions Holding TVTX

# of Institutions

239

Shares Held

99.9M

Call Options Held

1.79M

Put Options Held

555K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.02B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Travere Therapeutics, Inc. Transaction History